Chronic Disease
Chronic Disease
Modeling Health
Approximately half of all U.S. adults suffer from at least one chronic condition. Schaeffer Scholars are modeling the value of treatments and interventions that will reduce this burden.
Related Topics
Top Stories View All
Journal Article
Cost-Effectiveness of Gene Therapy for Sickle Cell Disease in Uganda: Tailoring High-Income Evidence to Uganda’s Context
Featured Experts: J. Felipe Montano-Campos
In The News View All
Medscape
Peters interviewed about how new GLP-1 guidelines and price reductions will affect patients
Featured Experts: Anne Peters
NPR
Joyce interviewed about White House deal lowering prices on anti-obesity medications
Featured Experts: Geoffrey Joyce
HealthDay
Avoiding sleep drugs could improve older Americans’ health and longevity, USC Schaeffer research shows
Featured Experts: Hanke Heun-Johnson, Jason Doctor
The Academic Minute
Chapel discusses his “diabetes paradox” research showing health gains haven’t led to labor gains among people with diabetes
Featured Experts: Jack M. Chapel
Reuters
As insurers cut back on GLP-1 coverage, Peters says some patients are stretching doses
Featured Experts: Anne Peters
Featured Testimony
Testimony on Incentivizing Chronic Disease Prevention and Treatment
Rebalancing the healthcare system to favor prevention and cures can potentially reduce the long-term burden of chronic diseases.
Experts: Anne Peters
Featured Article
The Economic Case for Public Investment in Stem Cell Research
Our analysis shows the measure resulted in over 56,000 jobs created and added approximately $10 billion to the state’s economy.
Experts: Dana Goldman, Bryan Tysinger
